• ABOUT US
    ▼
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    ▼
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    ▼
    • Pipeline
    • VIS171
    • VIS513
  • FOR PATIENTS
    ▼
    • Clinical Trials
  • CAREERS
    ▼
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Visterra

We Bring Better Biologics to Life

  • ABOUT US
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    • Pipeline
    • VIS171
    • VIS513
  • FOR PATIENTS
    • Clinical Trials
  • CAREERS
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Publications

Publications

Featured publications

Accelerating Characterization of Therapeutic Antibodies: A Comparative Assessment of icIEF-UV/MS and the Traditional Fractionation Workflow

July 28, 2025 | Journal of the American Society for Mass Spectrometry
Arnik Shah, et al.

Accelerating Characterization of Therapeutic Antibodies: A Comparative Assessment of icIEF-UV/MS and the Traditional Fractionation Workflow

Arnik Shah, Parth Shah, Alex Johnson, Jean Bender, Dmitry Gumerov, Jingwen Ding, Scott Mack, Matthew D. Stone, Maggie A. Ostrowski

>READ

A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy

November 2, 2023 | The New England Journal of Medicine
Mohit Mathur, et al.

A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy

Mohit Mathur, Jonathan Barratt, Bobby Chacko, Tak Mao Chan, Laura Kooienga, Kook-Hwan Oh, Manisha Sahay, Yusuke Suzuki, Muh Geot Wong, Jill Yarbrough, Jing Xia, Brian J G Pereira

>READ

Multi-omic single cell sequencing: Overview and opportunities for kidney disease therapeutic development

April 5, 2023 | Frontiers in Molecular Biosciences
Steven Pregizer, et al.

Multi-omic single cell sequencing: Overview and opportunities for kidney disease therapeutic development

Steven Pregizer, Thom Vreven, Mohit Mathur, Luke Robinson

>READ

Antigenically intact hemagglutinin in circulating avian and swine influenza viruses and potential for H3N2 pandemic.

April 23, 2013 | PLoS One
Karunya Srinivasan et al.

Antigenically intact hemagglutinin in circulating avian and swine influenza viruses and potential for H3N2 pandemic.

Karunya Srinivasan, Rahul Raman, Akila Jayaraman, Karthik Viswanathan, Ram Sasisekharan

>READ

Modular glycosphere assays for high-throughput functional characterization of influenza viruses.

April 15, 2013 | BMC Biotechnology
Sven N Hobbie et al.

Modular glycosphere assays for high-throughput functional characterization of influenza viruses.

Sven N Hobbie, Karthik Viswanathan, Ido Bachelet, Udayanath Aich, Zachary Shriver, Vidya Subramanian, Rahul Raman, Ram Sasisekharan

>READ

Redesign of a cross-reactive antibody to dengue virus with broad-spectrum activity and increased in vivo potency.

April 8, 2013 | Proceedings of the National Academy of Sciences of the United States of America
Kannan Tharakaraman et al.

Redesign of a cross-reactive antibody to dengue virus with broad-spectrum activity and increased in vivo potency.

Kannan Tharakaraman, Luke N Robinson, Andrew Hatas, Yi-Ling Chen, Liu Siyue, S Raguram, V Sasisekharan, Gerald N Wogan, Ram Sasisekharan

>READ

Quantitative description of glycan-receptor binding of influenza A virus H7 hemagglutinin.

February 20, 2013 | PloS One
Karunya Srinivasan et al.

Quantitative description of glycan-receptor binding of influenza A virus H7 hemagglutinin.

Karunya Srinivasan, Rahul Raman, Akila Jayaraman, Karthik Viswanathan, Ram Sasisekharan

>READ

Glycosylation at Asn91 of H1N1 haemagglutinin affects binding to glycan receptors.

December 19, 2011 | Scientific Reports
Venkataramanan Soundararajan et al.

Glycosylation at Asn91 of H1N1 haemagglutinin affects binding to glycan receptors.

Venkataramanan Soundararajan, Shu Zheng, Neel Patel, Ken Warnock, Rahul Raman, Ian A Wilson, S Raguram, V Sasisekharan, Ram Sasisekharan

>READ

Glycomics-based analysis of chicken red blood cells provides insight into the selectivity of the viral agglutination assay.

April 20, 2011 | The FEBS Journal
Udayanath Aich et al.

Glycomics-based analysis of chicken red blood cells provides insight into the selectivity of the viral agglutination assay.

Udayanath Aich, Nia Beckley, Zachary Shriver, Rahul Raman, Karthik Viswanathan, Sven Hobbie, Ram Sasisekharan

>READ

A single base-pair change in 2009 H1N1 hemagglutinin increases human receptor affinity and leads to efficient airborne viral transmission in ferrets.

March 2, 2011 | PLoS One
Karthik Viswanathan et al.

A single base-pair change in 2009 H1N1 hemagglutinin increases human receptor affinity and leads to efficient airborne viral transmission in ferrets.

Karthik Viswanathan, Xiaoying Koh, Aarthi Chandrasekaran, Claudia Pappas, Rahul Raman, Aravind Srinivasan, Zachary Shriver, Terrence M Tumpey, Ram Sasisekharan

>READ

Determinants of glycan receptor specificity of H2N2 influenza A virus hemagglutinin.

October 29, 2010 | PLoS One
Karthik Viswanathan et al.

Determinants of glycan receptor specificity of H2N2 influenza A virus hemagglutinin.

Karthik Viswanathan, Aarthi Chandrasekaran, Aravind Srinivasan, Rahul Raman, V Sasisekharan, Ram Sasisekharan

>READ

Glycans as receptors for influenza pathogenesis.

August 24, 2010 | Glycoconjugate Journal
Karthik Viswanathan et al.

Glycans as receptors for influenza pathogenesis.

Karthik Viswanathan, Aarthi Chandrasekaran, Aravind Srinivasan, Rahul Raman, V Sasisekharan, Ram Sasisekharan

>READ

Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957.

June 21, 2010 | PLoS One
Claudia Pappas et al.

Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957.

Claudia Pappas, Karthik Viswanathan, Aarthi Chandrasekaran, Rahul Raman, Jacqueline M Katz, Ram Sasisekharan, Terrence M Tumpey

>READ
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • Next Page »

© 2025 Visterra, Inc. Terms of usePrivacy PolicySite Design: Fassino/Design

We use cookies on our website to see how you interact with it. By accepting, you agree to our use of such cookies. Privacy PolicyOk